Legal & General Group Plc - SIGILON THERAPEUTICS INC ownership

SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 53 filers reported holding SIGILON THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of SIGILON THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$1,000
-50.0%
1,2310.0%0.00%
Q1 2022$2,000
-33.3%
1,2310.0%0.00%
Q4 2021$3,000
-57.1%
1,2310.0%0.00%
Q3 2021$7,0000.0%1,231
+96.0%
0.00%
Q2 2021$7,000
-58.8%
628
-19.8%
0.00%
Q1 2021$17,0007830.00%
Other shareholders
SIGILON THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 10,370,369$28,622,0000.44%
HARBOURVEST PARTNERS LLC 740,740$2,044,0000.26%
SOUNDMARK WEALTH MANAGEMENT, LLC 25,555$71,0000.05%
Artal Group S.A. 276,000$762,0000.02%
Choate Investment Advisors 66,666$184,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 200,000$552,0000.01%
CANADA PENSION PLAN INVESTMENT BOARD 1,485,185$4,099,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 142,781$394,0000.00%
STATE OF WISCONSIN INVESTMENT BOARD 509,629$1,407,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 234,153$646,0000.00%
View complete list of SIGILON THERAPEUTICS INC shareholders